Roderick Wong
@Rtw Investments, Lp
Latest period2024 - Q3ReportedManaged Assets$6.911BTotal holdings68
Assets growth rate7%Assets growth rate (2-Q avg)1.18%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Rtw Investments, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.
Assets under management
The assets under management (AUM) of Rtw Investments, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.911B in assets, with a quarterly growth rate of 7% and a 2-quarter average growth rate of 1.18%. The portfolio is managed by Roderick Wong, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
AXSMAxsome Therapeutics Inc
| 5.45% | $376.515M 4.19M shares@ $89.88 avg price | Decreased -9.59% |
RNAAvidity Biosciences Inc
| 5.41% | $373.543M 8.133M shares@ $45.93 avg price | Decreased -7.65% |
INSMInsmed Inc
| 3.46% | $238.857M 3.272M shares@ $73.0 avg price | Decreased -10.11% |
ALKSAlkermes Plc
| 2.7% | $186.246M 6.654M shares@ $28.0 avg price | Decreased -5.71% |
RDNTRadnet Inc
| 1.82% | $125.499M 1.809M shares@ $69.4 avg price | Decreased -2.55% |
ESTAEstablishment Labs Hldgs Inc
| 1.66% | $114.48M 2.646M shares@ $43.28 avg price | Decreased -1.12% |
RAREUltragenyx Pharmaceutical In
| 1.59% | $109.323M 1.968M shares@ $55.55 avg price | Decreased -39.63% |
ARVNArvinas Inc
| 1% | $68.529M 2.782M shares@ $24.63 avg price | Decreased -6.25% |
TSHATaysha Gene Therapies Inc
| 0.44% | $30.042M 14.946M shares@ $2.01 avg price | Decreased -20.49% |
SABSSab Biotherapeutics Inc
| 0.03% | $1.715M 635,276 shares@ $2.7 avg price | Decreased -17.16% |